Asylia Diagnostics

Foundation date

03/05/2019

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

At Asylia Diagnostics we are building a technology platform that will permit a quick and efficient high-resolution profiling of tumor microenvironment, different immune cells and their subtypes, and cell signaling. With the right data at hand, it will unlock an opportunity to discover novel biomarkers and modes of action for investigational drugs.

Upcoming events

Latest news

  • Mithra appoints experienced life sciences executive Christian Homsy* as Chairman

    1 day ago

  • Oxurion reaches enrollment target in KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema

    Friday May 26th 2023

  • How garbage disposal clogs in cells can lead to Alzheimer’s

    Friday May 26th 2023